Target intelligence / Profile preview

Alginate and Psl exopolysaccharide (Alginate, Psl)

Target
Alginate, Psl
Molecular classification
Other (bacterial exopolysaccharide), Biofilm matrix component
01

Overview

Alginate and Psl exopolysaccharides are two major glycans produced by *Pseudomonas aeruginosa* that form a crucial part of the bacterial biofilm matrix[1][3][5][7]. Alginate is a high-molecular-weight polymer of mannuronic and guluronic acids, typically associated with the "mucoid" phenotype found in chronic infections (especially cystic fibrosis). Alginate provides structural integrity to mature biofilms and contributes to evasion of the immune system and antibiotic resistance[1][3][5]. Psl is a neutral polysaccharide composed mainly of mannose, rhamnose, and glucose. Psl is essential for initial attachment to surfaces and intercellular cohesion during early biofilm formation[3][5][6][7]. Both exopolysaccharides play complementary roles in biofilm architecture, communal stress resistance, and chronic infection establishment. Their synthesis is tightly regulated and involves complex genetic and protein machinery[1][3][6]. Inhibiting or degrading these exopolysaccharides is a promising, though challenging, strategy for managing persistent bacterial infections.

Other names
alginatealginate polysaccharidePslPsl polysaccharidePsl EPS
02

Mechanism of action

Enzymatic degradation of exopolysaccharide (e.g., alginate lyase cleaves alginate, PslG hydrolyzes Psl EPS to disrupt biofilm structure)\nBiofilm dispersal agents interfere with EPS synthesis or stability

03

Biological functions

Structural scaffold of biofilm matrixCell adhesion (Psl: cell-to-cell and cell-surface attachment; Alginate: biofilm stabilization)Protection from host defense and environmental stress (including antimicrobials, oxidative stress)Regulation of biofilm developmental stages
04

Disease associations

Infection (primarily chronic infections with *Pseudomonas aeruginosa*, especially in cystic fibrosis and device-related infections)Antibiotic resistance (contributes to reduced drug penetration in biofilms)Immune evasion (protects bacteria from immune clearance)
05

Safety considerations

Polysaccharide matrix protects bacteria from host immunity and antimicrobials, leading to persistent, hard-to-treat infectionsTargeting and degrading EPS must avoid excessive inflammatory reaction or toxicityBiofilm disruption may release bacteria, risking acute infection events
06

Interacting drugs

Alginate lyase

2 more in the full profile.

07

Biomarkers

Overproduction of alginate marks “mucoid” *P. aeruginosa* strains in cystic fibrosisExpression of Psl-specific antigens can be used to characterize biofilm-forming strains

Beyond the preview

Go deeper on Alginate and Psl exopolysaccharide (Alginate, Psl).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alginate and Psl exopolysaccharide (Alginate, Psl).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call